Ballentine Partners’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Hold
16,793
﹤0.01% 1022
2026
Q1
$163K Sell
16,793
-1,277
-7% -$11.7K ﹤0.01% 959
2025
Q4
$173K Sell
18,070
-240
-1% -$2.44K ﹤0.01% 935
2025
Q3
$179K Buy
+18,310
New +$141K ﹤0.01% 938

Other funds holding PRTA

Ballentine Partners's PRTA Position: Q2 2026 in Review

Ballentine Partners held its Prothena Corp (PRTA) position steady in Q2 2026 at 16,793 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Ballentine Partners first reported a position in PRTA in Q3 2025 and has held it in 4 quarters since. The position peaked at $179K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Ballentine Partners held 16,793 shares of Prothena Corp worth $164K as of Q2 2026.
  • Ballentine Partners left its Prothena Corp share count unchanged in Q2 2026.
  • Prothena Corp made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1022 holding.
  • Ballentine Partners first reported a position in Prothena Corp in Q3 2025 and has held it in 4 quarters since.
  • Ballentine Partners's Prothena Corp position peaked at $179K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.